| Dr Kevin Morgan Dr Fiona Thomas |
|||
Dr Kevin Morgan MA(Oxon), PhD |
Selected Publications |
||
Research Focus
Kevin leads exploratory research by the Discovery Research Group. |
Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, Pineda R, Gottsch ML, Tena-Sempere M, Moenter SM, Terasawa E, Clarke IJ, Steiner RA, Millar RP. J Neurosci. 2009;29:3920-9. Retention and silencing of prepro-GnRH-II and type II GnRH receptor genes in mammals. Stewart AJ, Katz AA, Millar RP, Morgan K. Neuroendocrinology 2009 In press. |
||
| Research Programmes | |||
| Structural and Molecular Basis of Ligand-induced Selective Signalling (LiSS) in G Protein-coupled Receptors (GPCRs) G protein-coupled receptor integrative and ligand-induced selective signalling in the reproductive system Development and application of GnRH analogues : application in cancers and the reproductive tract |
|||
Contact |
|||
| Email: k.morgan@hrsu.mrc.ac.uk Telephone: 0131 242 6219. Fax: 0131 242 6197 | |||
| Biographical Profile | |||
Kevin studied biochemistry at Oxford University and obtained a PhD from Leicester University. He has a background in molecular genetics, neuroendocrinology and cell biology, having published research relating to the renin-angiotensin system, the discovery of a novel neuroendocrine sodium channel subunit and the gonadotropin releasing hormone system. |
|||
| Dr Fiona Thomas BSc (Hons), PhD | Selected Publications | ||
Research Focus Angiogenesis is essential for ovarian follicle development. I am currently leading research projects on the regulation and manipulation of the follicular vasculature, within a programme led by Professor Hamish Fraser . Our aims are to identify which molecules regulate the process of angiogenesis and find out if abnormal production of these molecules could contribute to disorders of the ovary, such as inadequate follicular development and infertility, polycystic ovary syndrome and ovarian hyperstimulation syndrome. We aim to develop novel therapeutics by targeting specific angiogenic factors or their inhibitors to the ovary during the ovulatory cycle. |
Thomas FH, Ethier JF, Shimasaki S, Vanderhyden BC (2005). Follicle-stimulating hormone regulates oocyte growth by modulation of expression of oocyte and granulosa cell factors. Endocrinology 146: 941-949 Thomas FH, Vanderhyden BC (2006). Oocyte growth and developmental competence. In 'In-vitro Maturation of Human Oocytes: Basic Research to Clinical Applications'. Tan, Chian and Buckett (eds), in press |
||
| Editorial Boards | |||
Reproductive Biology and Endocrinology (Adviser) |
|||
| Society Memberships | |||
| Society for the Study of Reproduction | |||
| Research Programmes | Contact (e-mail, fax) | Telephone | |
| f.thomas@hrsu.mrc.ac.uk Fax: +44 (0)131 242 6197 |
+44 (0)131 242 9100 |
||
| Back to top | |||
Home | News | Profile | Research | Training & Careers | Vacancies | Publications | Seminars | Public Events | Schools | Support Services|Location | Contact | Links | Glossary |
||
Privacy Statement, Data Protection & Freedom of Information Page maintained by webservices@hrsu.mrc.ac.uk Copyright Medical Research Council Human Reproductive Sciences Unit 2008. All rights reserved. |
||